Myovant Sciences Ltd. (MYOV)

20.94 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

New York Stock Exchange : Healthcare

Prev Close 20.94

Price Open 21.03

Volume: 65,105

Avg Volume: 133,440

Market Cap: 1.43B

P/E Ratio -20.13

52 Wk Range 10.7-25.54



MYOV Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
66.52M
529,596
3.25
0.80%

2018-07-13
63.17M
568,929
5.56
0.90%

2018-06-29
63.17M
546,359
9.32
0.86%

2018-06-15
63.17M
565,204
10.87
0.89%




MYOV Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-07
Q4 2018
N/A
-0.77 (1)
-0.81
-0.04

2018-02-13
Q3 2018
N/A
-0.42 (2)
-0.70
-0.28

2017-11-13
Q2 2018
N/A
-0.38 (2)
-0.50
-0.12

2017-08-10
Q1 2018
N/A
-0.29 (2)
-0.39
-0.10

News

Myovant Sciences misses by $0.13 (2018-08-07 17:05 SeekingAlpha)

Myovant Sciences (NYSE: MYOV ): Q2 EPS of -$0.98 misses by $0.13 . More news on: Myovant Sciences, Earnings news and commentary, Healthcare stocks news, Read more …

 

Myovant Provides Corporate Update and Reports Financial Results for First Fiscal Quarter Ended June 30, 2018 (2018-08-07 16:30 PR Newswire)

BASEL, Switzerland , Aug.7, 2018 /PRNewswire/ --Myovant Sciences (NYSE:MYOV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of women's health and endocrine diseases, today announced corporate upd…

 


Statistics

Shares Outstanding: 68.23M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 23.86

Revenue: N/A

Gross Profit: N/A

Cash: 258.21M

Debt: N/A

Return On Assets: -114.60

Return On Equity: -176.65

Profit Margin: N/A

Price History

Beta: -2.33

50-day Moving Avg: 22.07

200-day Moving Avg: 17.85

YTD Change: 68.06

5-day Change: -1.74

1-month Change: 2.20

3-month Change: -3.50

6-month Change: 41.01

1-year Change: 110.88

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Myovant Sciences Ltd.

Exchange: New York Stock Exchange

Industry: Biotechnology

Sector: Healthcare

Website: http://www.myovant.com

Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.